Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Alternative Medications to Diazepam for Seizure Management

First-Line Alternatives for Status Epilepticus

  • Valproic acid is at least as effective as phenytoin for refractory status epilepticus with potentially fewer adverse effects, as recommended by the Neurocritical Care Society's Status Epilepticus Guideline Writing Committee based on high-level evidence 1, 2
  • Seizure control is achieved in 79% of patients when valproic acid is used as a second-line agent versus 25% with phenytoin in one study 1
  • The recommended dosing for valproic acid is 30 mg/kg IV at 6 mg/kg per hour followed by maintenance of 1-2 mg/kg per hour, with valproic acid not associated with hypotension unlike phenytoin which caused hypotension in 12% of patients in comparative studies 1
  • Levetiracetam demonstrates efficacy in managing status epilepticus with seizure cessation rates of 67-73%, and is well-tolerated with minimal adverse effects in multiple studies 2, 3
  • The American College of Emergency Physicians guidelines recommend specific anti-absence medications, such as ethosuximide or valproic acid, rather than benzodiazepines for absence seizures 5

Comparative Efficacy and Safety Profile

  • Valproate and levetiracetam show similar efficacy (68% vs 73%) for refractory status epilepticus, with valproate having fewer adverse effects compared to phenytoin 1, 2
  • Phenytoin has more adverse effects including hypotension (12% of patients) compared to valproate, and its efficacy rate is approximately 84-88% in controlling seizures within 20 minutes of infusion 1, 4

Clinical Decision Algorithm

  • For active status epilepticus after benzodiazepine failure, the first choice is IV valproate 30 mg/kg, with alternative options including IV levetiracetam 20-30 mg/kg or IV phenytoin/fosphenytoin, with monitoring for hypotension 1, 2, 3, 4

Pitfalls and Caveats

  • Delay in treatment of status epilepticus increases mortality and morbidity, and prompt initiation of treatment is crucial, with the need to always search for and treat underlying causes of status epilepticus (hypoglycemia, hyponatremia, infection, etc.) 1, 6